triazoles has been researched along with Autism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anagnostou, E; Ashford, E; Chatham, C; Clinch, S; Hollander, E; Jacob, S; Jou, R; McCracken, J; McNamara, N; Murphy, D; Murtagh, L; Noeldeke, J; Sanders, K; Sikich, L; Smith, J; Tobe, R; Veenstra-VanderWeele, J | 1 |
| Catterall, WA; Han, S; Jones, CJ; Scheuer, T; Tai, C | 1 |
| Anderson, R; Carlson, G; Gandal, MJ; Gur, RE; Jonak, G; Klook, K; Leitman, V; Liang, Y; Ortinski, PI; Pierce, RC; Siegel, SJ; Sisti, J; Thieu, T | 1 |
3 other study(ies) available for triazoles and Autism
| Article | Year |
|---|---|
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program.
Topics: Autism Spectrum Disorder; Autistic Disorder; Benzodiazepines; Humans; Pyridines; Quality of Life; Randomized Controlled Trials as Topic; Triazoles | 2022 |
Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism.
Topics: Animals; Autistic Disorder; Behavior, Animal; Benzodiazepines; Brain; Disease Models, Animal; Fluorobenzenes; Interpersonal Relations; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Protein Subunits; Pyridines; Receptors, GABA-A; Social Behavior; Synaptic Transmission; Triazoles; Zolpidem | 2014 |
GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.
Topics: Animals; Autistic Disorder; Baclofen; Disease Models, Animal; Evoked Potentials, Auditory; Exploratory Behavior; Fluorobenzenes; GABA-B Receptor Agonists; In Situ Hybridization; Intellectual Disability; Interneurons; Male; Mice; Mice, Transgenic; Parvalbumins; Phenotype; Pyramidal Cells; Receptors, N-Methyl-D-Aspartate; Risperidone; Schizophrenia; Social Behavior; Synaptic Potentials; Triazoles | 2012 |